Stock NAMS FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

Real-time Estimate Tradegate
Other stock markets
 01:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
18.25 EUR -7.59% Intraday chart for Frazier Lifesciences Acquisition Corporation +15.43% +76.81%
11/06 NewAmsterdam Pharma Gets Another US Patent Extending IP Protection for Obicetrapib Until July 2043 MT
10/06 Transcript : NewAmsterdam Pharma Company N.V. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 10:40 AM

Chart calendar Frazier Lifesciences Acquisition Corporation

b.AGvZ2ZrNlY_lVgvl5hqXhQqN9a2WY0BH2XoP2TPGk_s.Mh_to-KM7_aiZ1m61GjQ6zP82J7ANXQQuD59mkGfpstSNK70-avh-bcaTg~ceb640935749c54168ec599a3277d38e

Upcoming events on Frazier Lifesciences Acquisition Corporation

05/08/2024 Q2 2024 Earnings Release (Projected)
11/11/2024 Q3 2024 Earnings Release (Projected)
28/03/2025 Q4 2024 Earnings Release (Projected)
07/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Frazier Lifesciences Acquisition Corporation

10/06/2024 08:10 pm Goldman Sachs Global Healthcare Conference
06/06/2024 03:30 am Annual General Meeting
06/06/2024 12:30 am Jefferies Global Healthcare Conference
01/06/2024 11:35 pm National Lipid Association Scientific Conference - Abstract Number: 141
01/06/2024 03:00 am National Lipid Association Scientific Conference - Abstract Number: 139
01/06/2024 03:00 am National Lipid Association Scientific Conference - Abstract Number: 140
01/06/2024 03:00 am National Lipid Association Scientific Conference - Abstract Number: 127
01/06/2024 03:00 am National Lipid Association Scientific Conference - Abstract Number: 138
01/06/2024 03:00 am National Lipid Association Scientific Conference - Abstract Number: 128
28/05/2024 06:54 pm European Atherosclerosis Society Congress
28/05/2024 06:47 pm European Atherosclerosis Society Congress - Session Name: 0660
28/05/2024 05:42 pm European Atherosclerosis Society Congress - Session Name: 0601
27/05/2024 06:12 pm European Atherosclerosis Society Congress - Session Name: 0390
16/05/2024 06:30 pm R&D Day - Key Opinion Leader
15/05/2024 02:05 am RBC Capital Markets Global Healthcare Conference
09/05/2024 05:30 pm Q1 2024 Earnings Release
07/04/2024 10:45 pm American College of Cardiology Scientific Meeting
12/03/2024 Jefferies Biotech on the Bay Summit
12/03/2024 01:30 am Leerink Partners Global Biopharma Conference
05/03/2024 12:40 am TD Cowen Health Care Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million EUR		Released
Forecast
Spread 		0,00


97,5
98,2
-0.69%		13,0
14,2
-8.63%
8,64

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million EUR		Released
Forecast
Spread 		0,00


-6,96
7,11
-197.91%		-169
-172
2.01%
-187

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		0,00


-78,1
7,00
-1215.03%		-163
-169
3.52%
-207

Net income
Million EUR		Released
Forecast
Spread 		-28,6


-78,1
7,00
-1215.03%		-163
-167
2.45%
-210

EPS
EUR		Released
Forecast
Spread 		-2,53


-0,96
0,08
-1300%		-1,98
-2,03
2.24%
-2,34

Announcement Date04/08/2231/03/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million EUR		Released
Forecast
Spread
3,50


1,75

4,00
7,20
-44.44%
1,47


1,95

9,56



1,77

1,30
1,61
-18.88%
1,11


1,84


4,56


0,00


0,00

EBITDA
Million EUR		Released
Forecast
Spread









27,6


29,0

























EBIT
Million EUR		Released
Forecast
Spread
-25,5


-25,8





-34,2


-36,7





-48,0

-51,6
-46,7
-10.55%
-50,5


-45,8


-39,6


-41,9


-37,3

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread



-39,3





-33,7


-37,5





-48,2

-93,8
-36,2
-158.85%
-47,6


-42,0


-37,2


-38,5


-33,9

Net income
Million EUR		Released
Forecast
Spread



-39,2





-33,7


-36,1

-75,1



-46,9

-93,8
-43,6
-115.03%
-48,3


-42,3


-37,7


-38,5


-33,9

EPS
EUR		Released
Forecast
Spread



-0,45





-0,41


-0,43

-0,92



-0,56

-0,99
-0,49
-101.98%
-0,54


-0,47


-0,42


-0,40


-0,35

Announcement Date--31/03/23--07/08/23-08/05/24-----

Upcoming sector events for Frazier Lifesciences Acquisition Corporation

24/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
25/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 10:30 am ARGENX SE: Q2 2024 Earnings Release
30/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
31/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Frazier Lifesciences Acquisition Corporation

05/06/2024 01:21 pm PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 04:30 pm AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 05:16 pm BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 10:30 am ZEALAND PHARMA A/S: Q1 2024 Earnings Release
16/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 05:35 pm THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 04:30 pm CABALETTA BIO, INC.: Q1 2024 Earnings Release
15/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 01:35 am ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 01:30 am ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. Calendar Frazier Lifesciences Acquisition Corporation